Literature DB >> 18572004

Sequential treatment of giant basal cell carcinomas.

V Madan1, C A West, J V Murphy, J T Lear.   

Abstract

Treatment of giant basal cell carcinomas (GBCC) can pose several challenges. In such instances, use of routine and recommended treatments for sporadic, average size basal cell carcinomas (BCC) is suboptimal, impractical and often leads to treatment failure. Surgical excision of such large lesions results in marked intra and postoperative morbidity. While individually, photodynamic therapy, topical imiquimod and surgical excision are all established treatments for BCC, their combined use in the treatment of GBCC has not been explored. Three patients with histologically proven GBCC were sequentially treated with three cycles of metvix photodynamic therapy followed by a 6-week course of topical imiquimod. This led to a reduction in the size of these lesions which were subsequently excised.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18572004     DOI: 10.1016/j.bjps.2007.12.076

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

Review 1.  Giant anterior chest wall basal cell carcinoma: a reconstructive challenge and review of the literature.

Authors:  James Warbrick-Smith; Jennifer K O'Neill; Paul Wilson
Journal:  BMJ Case Rep       Date:  2013-04-17

Review 2.  Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer.

Authors:  Silvia Rocío Lucena; Nerea Salazar; Tamara Gracia-Cazaña; Alicia Zamarrón; Salvador González; Ángeles Juarranz; Yolanda Gilaberte
Journal:  Int J Mol Sci       Date:  2015-10-28       Impact factor: 5.923

3.  Giant Anterior Chest Wall Basal Cell Carcinoma: An Approach to Palliative Reconstruction.

Authors:  Pauline Joy F Santos; Christina Prendergast; Amber Leis
Journal:  Case Rep Oncol Med       Date:  2016-12-19

4.  Aminolevulinic Acid-photodynamic therapy of Basal cell carcinoma and factors affecting the response to treatment: a clinical trial.

Authors:  Zohreh Tehranchinia; Hoda Rahimi; Mahsa Seyed Ahadi; Maral Seyed Ahadi
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.